Compositions comprising a modified GIcNAc-1-phosphotransferase and methods of use thereof
AssigneeWashington University
InventorsStuart Kornfeld, Lin Liu, Wang Lee, Balraj Doray
Life of this patent
Estimating the term…
Abstract
The disclosure provides a modified UDP-GlcNAc:Lysosomal Enzyme GlcNAc phosphotransferase with enhanced ability to phosphorylate lysosomal enzymes and methods of use thereof.
Claims8
A method to increase binding of a protein of interest to cell surface mannose 6-phosphate receptor (Man-6-P), the method comprising expressing a modified GlcNAc-1-PT α/β subunit in a cell, wherein the modified GlcNAc-1-PT α/β subunit comprises an internal deletion of amino acids with reference to full-length human GlnNAc-1-PT α/β subunit having the sequence of SEQ ID NO:1, wherein amino acids 86 to 322 and amino acids 438 to 928 are deleted, and wherein the increased binding of a protein of interest to cell surface mannose 6-phosphate receptor (Man-6-P) is compared to the binding of a protein of interest to cell surface mannose 6-phosphate receptor (Man-6-P) in a cell expressing endogenous GlcNAc-1-PT α/β subunit.
Dependencies are inferred from the claim text.